Keyphrases
Diabetic
100%
Islet Xenograft
100%
Porcine Islets
100%
Macaque
100%
Macaque Model
100%
Islet Transplantation
37%
Diabetes Reversal
37%
Translational Value
37%
Nonhuman Primate
25%
Weight Loss
25%
Graft Function
25%
Glycemic Control
25%
Mild Hyperglycemia
25%
Model Limitations
25%
Clinical Trials
12%
Efficacy Study
12%
Safety Study
12%
Immunosuppression
12%
Islet
12%
Nutritional Status
12%
Type 1 Diabetic
12%
Metabolic
12%
High Dose
12%
Insulin Therapy
12%
Physiological Response
12%
Causal Factors
12%
Orally Administered
12%
Gastrointestinal Tract
12%
Systemic Exposure
12%
Low Bioavailability
12%
Potential Model
12%
Long-term Graft Survival
12%
Confounding
12%
Infectious Complications
12%
Long-term Survival
12%
Blood Glucose
12%
C-peptide Levels
12%
Therapeutic Levels
12%
Source Type
12%
Accurate Interpretation
12%
Nutritional Deficiency
12%
Human Species
12%
Xenograft Model
12%
Insulin Production
12%
Species Mixture
12%
Noninfectious Complications
12%
Insulin Kinetics
12%
International Xenotransplantation Association
12%
Transplant Experiment
12%
Transplantation Model
12%
Dose Level
12%
Body Weight Gain
12%
Medicine and Dentistry
Transplantation
100%
Diabetes
100%
Xenograft
100%
Glycemic Control
66%
Diabetes Mellitus
66%
Hyperglycemia
66%
Xenotransplantation
33%
Islet Transplantation
33%
Clinical Trial
33%
Drug Megadose
33%
Efficacy Study
33%
Insulin Treatment
33%
Immunosuppressive Treatment
33%
Graft Survival
33%
Nutritional Status
33%
Long Term Survival
33%
Body Weight Gain
33%
C-Peptide
33%
Nutritional Deficiency
33%
Gastrointestinal Tract
33%
Bioavailability
33%
Body Weight Loss
33%
Blood Glucose
33%
Immunosuppressant
33%
Immunology and Microbiology
Xenograft
100%
Pig
100%
Macaca
100%
Glycemic Control
18%
Islet Transplantation
9%
Immunosuppression
9%
Gastrointestinal Tract
9%
Drug Megadose
9%
Glucose Blood Level
9%
Long Term Survival
9%
Body Weight Gain
9%
Body Weight Loss
9%
Normal Value
9%
Xenotransplantation
9%
Biochemistry, Genetics and Molecular Biology
Pig
100%
Macaca
100%
Hyperglycemia
18%
Glycemic Control
18%
Gastrointestinal Tract
9%
Clinical Trial
9%
Efficacy Study
9%
C-Peptide
9%
Glucose Blood Level
9%
Drug Megadose
9%
Long Term Survival
9%
Normal Value
9%
Body Weight Gain
9%
Body Weight Loss
9%